For years, the conversation has centered on one metric: how much weight patients can lose with increasingly potent GLP-1 ...
With respect to cardiovascular and renal outcomes, combined therapy with SGLT2 inhibitors and GLP-1 receptor agonists has scant benefit compared with using either drug alone in patients with type 2 ...
Combo treatment may work best for those who don't respond to GLP-1s alone, a recent review suggests. Image credit: Lajst/Getty Images Past research shows that most people taking a GLP-1 drug can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results